SCHEMBL6783474

SCHEMBL6783474

CN(NC1CC1)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28140784 0.87 ALDH1A1 (0.39)
SCHEMBL24083946 0.81 ADH1C (0.39)
SCHEMBL7727423 0.81 ADH1C (0.39)
SCHEMBL24329483 0.81 ADH1C (0.39)
SCHEMBL10424684 0.79 EPHX1 (0.42)
SCHEMBL934631 0.76 POLB (0.35)
SCHEMBL12303336 0.69
SCHEMBL19222000 0.67
SCHEMBL14724552 0.63 IRAK4 (0.34)
SCHEMBL8214008 0.63 IRAK4 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6821971-B2 FOR PROPHYALXIS OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, INFLAMMATORY BOWEL DISEASE (IBS), SEPTIC SHOCK, CARDIOPULMONARY DYSFUNCTION, ACUTE RESPIRATORY DISEASE, CACHEXIA THE PROCTER & GAMBLE COMPANY 2004-11-23 US claimed
CN-107849024-A With as indoleamine 2, the benzimidazole and imidazopyridine imido of 3 dioxygenase inhibitor activities are for benzamide compound 吉利德科学公司 2018-03-27 CN disclosed
CN-107567449-A Tricyclic piperidine compounds 埃科特莱茵药品有限公司 2018-01-09 CN disclosed